Dr. Ahmad Shabsigh practices Urology. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Ahmad Shabsigh is a published doctor. He has 51 publications published. The most current publication "Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis." He accepts Medicare payments and is registered with Medicare.gov.
NPI NUMBER | 1407025042 | |
NPPES Provider LastName | SHABSIGH | |
NPPES Provider FirstName | AHMAD | |
NPPES Provider ZIPCode | 432213502 | |
NPPES Provider State | OH | |
Specialty Description | Urology | |
Total Claim Count | 237.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1407025042 |
Last Name Of The Provider | SHABSIGH |
First Name Of The Provider | AHMAD |
View All |
Dr. Bodo E. Knudsen, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. David S. Sharp, MD | |
Dr. Frederick L. Taylor, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. James W. Simon, MD | |
Dr. Wayne L. Poll, MD | |
Dr. Srinivas S. Samavedi, MD | |
Dr. Herbert W. Riemenschneider, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Zachary N. Gordon, MD | |
Dr. Erin C. Akar, MD | |
Dr. Daryl J. McLeod, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Jason A. Orien, MD |